Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
QuintilesIMS
Fish and Richardson
US Department of Justice
Mallinckrodt
Julphar
Argus Health
Moodys
US Army

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088488

« Back to Dashboard

NDA 088488 describes HYDROXYZINE PAMOATE, which is a drug marketed by Barr, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, and Watson Labs, and is included in thirty-four NDAs. It is available from thirty-six suppliers. Additional details are available on the HYDROXYZINE PAMOATE profile page.

The generic ingredient in HYDROXYZINE PAMOATE is hydroxyzine pamoate. There are nineteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the hydroxyzine pamoate profile page.

Summary for 088488

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antiemetics
Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 088488

Suppliers and Packaging for NDA: 088488

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088488 ANDA Teva Pharmaceuticals USA, Inc. 0555-0324 0555-0324-02 100 CAPSULE in 1 BOTTLE (0555-0324-02)
HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088488 ANDA PD-Rx Pharmaceuticals, Inc. 43063-251 43063-251-10 10 CAPSULE in 1 BOTTLE, PLASTIC (43063-251-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 100MG HCL
Approval Date:Jun 15, 1984TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Teva
Mallinckrodt
Healthtrust
US Department of Justice
Chinese Patent Office
Daiichi Sankyo
McKesson
Cantor Fitzgerald
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot